Windtree Therapeutics, Inc. (WINT) Earnings History
Annual and quarterly earnings data from 1995 to 2024
Loading earnings history...
WINT EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
WINT Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
Download Data
Export WINT earnings history in CSV or JSON format
Free sign-in required to download data
Windtree Therapeutics, Inc. (WINT) Earnings Overview
As of May 8, 2026, Windtree Therapeutics, Inc. (WINT) reported trailing twelve-month net income of -$41M, reflecting +97.8% year-over-year growth. The company earned $-1531.62 per diluted share over the past four quarters.
Looking at the long-term picture, WINT's historical earnings data spans multiple years. The company achieved its highest annual net income of -$2M in fiscal 1996.
Windtree Therapeutics, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including CRVS (-$44M net income), NKTR (-$164M net income, -297.1% margin), AGIO (-$423M net income, -764.0% margin), WINT has comparable earnings metrics. Compare WINT vs CRVS →
WINT Earnings vs Peers
Earnings metrics vs comparable public companies
WINT Historical Earnings Data (1995–2024)
30 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$5M | +73.0% | -$25M | $-104.35 | - | - |
| 2023 | -$20M | +48.2% | -$18M | $-4711.54 | - | - |
| 2022 | -$39M | +42.0% | -$41M | $-56011.00 | - | - |
| 2021 | -$68M | -123.4% | -$77M | $-122924.00 | - | - |
| 2020 | -$30M | -10.2% | -$30M | $-93616.00 | - | - |
| 2019 | -$27M | -33.8% | -$25M | $-113138.00 | -13876.3% | -12572.2% |
| 2018 | -$21M | -11.3% | -$16M | $-999999.00 | -1148.4% | -905.8% |
| 2017 | -$18M | +53.3% | -$23M | $-999999.00 | -1242.2% | -1518.4% |
| 2016 | -$39M | +28.4% | -$38M | $-999999.00 | -1933.9% | -1862.7% |
| 2015 | -$55M | -25.2% | -$40M | $-999999.00 | -5589.7% | -4035.9% |
See WINT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs WINT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare WINT vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonWINT — Frequently Asked Questions
Quick answers to the most common questions about buying WINT stock.
Is WINT growing earnings?
WINT EPS is $-1531.62, with earnings growth accelerating to +97.8%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-41M.
What are WINT's profit margins?
Windtree Therapeutics, Inc. net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are WINT's earnings?
WINT earnings data spans 1995-2024. The accelerating earnings trend is +97.8% YoY. Historical data enables comparison across business cycles.